1. Home
  2. CDXS vs EPSN Comparison

CDXS vs EPSN Comparison

Compare CDXS & EPSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDXS
  • EPSN
  • Stock Information
  • Founded
  • CDXS 2002
  • EPSN 2005
  • Country
  • CDXS United States
  • EPSN Canada
  • Employees
  • CDXS N/A
  • EPSN N/A
  • Industry
  • CDXS Major Chemicals
  • EPSN Oil & Gas Production
  • Sector
  • CDXS Industrials
  • EPSN Energy
  • Exchange
  • CDXS Nasdaq
  • EPSN Nasdaq
  • Market Cap
  • CDXS 176.4M
  • EPSN 153.4M
  • IPO Year
  • CDXS 2010
  • EPSN N/A
  • Fundamental
  • Price
  • CDXS $2.47
  • EPSN $6.70
  • Analyst Decision
  • CDXS Buy
  • EPSN Strong Buy
  • Analyst Count
  • CDXS 2
  • EPSN 1
  • Target Price
  • CDXS $11.00
  • EPSN $7.00
  • AVG Volume (30 Days)
  • CDXS 532.0K
  • EPSN 45.7K
  • Earning Date
  • CDXS 05-14-2025
  • EPSN 05-14-2025
  • Dividend Yield
  • CDXS N/A
  • EPSN 3.73%
  • EPS Growth
  • CDXS N/A
  • EPSN N/A
  • EPS
  • CDXS N/A
  • EPSN 0.09
  • Revenue
  • CDXS $59,345,000.00
  • EPSN $31,522,775.00
  • Revenue This Year
  • CDXS $12.62
  • EPSN $41.35
  • Revenue Next Year
  • CDXS $22.11
  • EPSN N/A
  • P/E Ratio
  • CDXS N/A
  • EPSN $73.15
  • Revenue Growth
  • CDXS N/A
  • EPSN 2.58
  • 52 Week Low
  • CDXS $1.90
  • EPSN $4.95
  • 52 Week High
  • CDXS $6.08
  • EPSN $7.32
  • Technical
  • Relative Strength Index (RSI)
  • CDXS 53.65
  • EPSN 45.40
  • Support Level
  • CDXS $2.23
  • EPSN $6.33
  • Resistance Level
  • CDXS $2.59
  • EPSN $7.28
  • Average True Range (ATR)
  • CDXS 0.13
  • EPSN 0.28
  • MACD
  • CDXS 0.05
  • EPSN -0.05
  • Stochastic Oscillator
  • CDXS 81.82
  • EPSN 27.08

About CDXS Codexis Inc.

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

About EPSN Epsilon Energy Ltd. Common Share

Epsilon Energy Ltd is engaged in the acquisition, development, gathering, and production of natural gas and oil reserves. The operating segments of the company include Upstream segment activities including acquisition, development, and production of natural gas reserves on properties within the United States. The Gas Gathering segment partners with two other companies to operate a natural gas gathering system, and the corporate segment activities include corporate listing and governance functions of the corporation. The company generates revenue from the sale of crude oil and natural gas.

Share on Social Networks: